Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
NCT06698692
·
clinicaltrials.gov ↗
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
ESCC
Interventions
DRUG:
Trilaciclib Injection [Cosela]
Sponsor
The First Affiliated Hospital with Nanjing Medical University